For AI assistants & researchers — machine-readable summary of this page
What this page is: Delvantic's full research page for Charles Schwab Corporation (SCHW) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.
Our current read (analysis of 2026-08-13): Designation Gem · Cairn score +45 (−100…+100 Quality+Value blend) · Quality 65 · Value 28 · Sentiment 42 (timing only, not weighted) · Composite fair value $178.37 vs $105.87 at analysis
Page map (sections in order; each card carries a stable
reference-name attribute you can cite):
profile-header/price-overview— company profile, live quote, market capextended-analysis— the core: three AI lens reads with findings, scores, and the analyst memofuture-predictions— our forward price-band predictionsmarket-narrative/ai-findings/gpt-critique— narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)- Members-only sections (render as login gates for anonymous readers):
price-history,income-trend,key-metrics,financials(statement tables),insider-trading. The analysis above is public; the raw data tables require a free account.
More for machine readers: site briefing at
/llms.txt ·
any ticker resolves at delvantic.com/stock/TICKER ·
raw inputs are public-company filings and market data (via licensed data feeds);
every model, score, lens read, and prediction on this page is Delvantic's own analysis.
Charles Schwab Corporation
SCHW NYSEThe Charles Schwab Corporation is an American multinational financial services company headquartered in Westlake, Texas. It focuses on providing a broad suite of investment, brokerage, banking, and financial advisory services to individual investors, independent investment advisors, and institutional clients. Schwab offers retail brokerage accounts, online and mobile trading platforms, retirement and education savings accounts, and cash management solutions, alongside checking and savings products through its banking subsidiaries. The firm is a major provider of custodial, trading, and support services to registered investment advisors, and it distributes a wide range of investment products, including mutual funds, exchange-traded funds, and managed portfolios. Charles Schwab Corporation also delivers digital advisory offerings and personalized wealth management services for more complex financial needs. Founded in 1971 and originally based in San Francisco, the company today plays a central role in the U.S. financial system as a leading investment services provider and large-scale custodian of client assets.
Earnings Schedule
Checked daily · calendar updated Aug 13| Print date | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| Jul 21, 2026 | $1.55 | $1.62 +4.5% | — | — |
| Jun 8, 2026 | $0.33 | $0.49 +48.5% | — | — |
| Apr 16, 2026 | $1.40 | $1.43 +2.1% | — | — |
| Feb 5, 2026 | $0.88 | $1.04 +18.2% | — | — |
| Jan 28, 2026 | $3.09 | $3.33 +7.8% | — | — |
Green = beat the estimate, red = missed. An earnings print is the fastest way a thesis changes — our designations should be re-read after each one.
Recent SEC Filings
| Filed | Form | Document |
|---|---|---|
| Aug 13, 2026 | 144 | View |
| Aug 13, 2026 | 144 | View |
| Aug 12, 2026 | 8-K | View |
| Aug 12, 2026 | 144 | View |
| Aug 12, 2026 | 424B5 | View |
| Aug 11, 2026 | 4 | View |
| Aug 11, 2026 | 144 | View |
| Aug 11, 2026 | FWP | View |
| Aug 10, 2026 | 4 | View |
| Aug 10, 2026 | 4 | View |
| Aug 10, 2026 | 4 | View |
| Aug 10, 2026 | 424B5 | View |
Filings link to the SEC’s EDGAR system. Annual/quarterly reports (10-K, 10-Q, 20-F) carry the full story; 8-K/6-K current reports are the fastest signal that something material happened.
Price Overview
Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 4.65
Total Equity: $49.43B
Shares: 1,903,655,914
Total Debt: $0.00
Cash: $46.03B
EBITDA: N/A
Total Debt: $0.00
Cash: $46.03B
Revenue: $23.92B
Revenue: $23.92B
Revenue: $23.92B
Total Equity: $49.43B
Tax Rate: 22.8%
Equity: $49.43B
Total Debt: $0.00
Cash: $46.03B
Current Liabilities: N/A
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: $49.43B
Shares: 1,903,655,914
Shares: 1,903,655,914
CapEx: -$548.00M
Shares: 1,903,655,914
Stock Price: $107.89
Net Income: $8.85B
Industry Benchmarks
Income Statement (Annual)
Last updated: Aug 12, 2026 1:23pm (1d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $18.5B | $20.8B | $18.8B | $19.6B | $23.9B |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Expenses | $5.9B | $6.4B | $6.7B | $6.4B | $6.9B |
| Operating Income | — | — | — | — | — |
| Net Income | $5.9B | $7.2B | $5.1B | $5.9B | $8.9B |
| EBITDA | — | — | — | — | — |
| EPS | $2.84 | $3.52 | $2.55 | $3.00 | $4.67 |
| EPS (Diluted) | $2.83 | $3.50 | $2.54 | $2.99 | $4.65 |
Balance Sheet (Annual)
Last updated: Aug 12, 2026 12:58pm (1d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $63.0B | $40.2B | $43.3B | $42.1B | $46.0B |
| Total Current Assets | — | — | — | — | — |
| Total Assets | $667.3B | $551.8B | $493.2B | $479.8B | $491.0B |
| Current Liabilities | — | — | — | — | — |
| Long-Term Debt | $18.9B | — | — | — | — |
| Total Liabilities | $611.0B | $515.2B | $452.2B | $431.5B | $441.6B |
| Total Equity | $56.3B | $36.6B | $41.0B | $48.4B | $49.4B |
| Retained Earnings | $26.0B | $31.1B | $33.9B | $37.6B | $44.1B |
Cash Flow (Annual)
Last updated: Aug 12, 2026 1:23pm (1d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $2.1B | $2.1B | $19.6B | $2.7B | $9.3B |
| Capital Expenditure | -$916.0M | -$971.0M | -$700.0M | -$620.0M | -$548.0M |
| Free Cash Flow | $1.2B | $1.1B | $18.9B | $2.1B | $8.8B |
| Acquisitions (net) | — | — | — | — | — |
| Net Debt Issued / (Repaid) | $5.2B | $1.9B | — | — | — |
| Dividends Paid | -$1.8B | -$2.1B | -$2.3B | -$2.3B | -$2.3B |
| Stock Buybacks | $0 | -$3.4B | -$2.8B | $0 | -$7.3B |
| Net Change in Cash | $22.8B | -$34.6B | $15.8B | -$9.0B | $4.1B |
Growth Trends (YoY %)
Last updated: Aug 12, 2026 1:23pm (1d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +12.1% | -9.3% | +4.1% | +22.0% |
| Gross Profit Growth | — | — | — | — |
| Operating Income Growth | — | — | — | — |
| Net Income Growth | +22.7% | -29.5% | +17.3% | +49.0% |
| EBITDA Growth | — | — | — | — |
Dividend History (Last 20)
Last updated: Aug 12, 2026 12:59pm (1d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-05-08 | $0.32 | — | — | — |
| 2026-02-13 | $0.32 | — | — | — |
| 2025-11-14 | $0.27 | — | — | — |
| 2025-08-08 | $0.27 | — | — | — |
| 2025-05-09 | $0.27 | — | — | — |
| 2025-02-14 | $0.27 | — | — | — |
| 2024-11-08 | $0.25 | — | — | — |
| 2024-08-09 | $0.25 | — | — | — |
| 2024-05-09 | $0.25 | — | — | — |
| 2024-02-08 | $0.25 | — | — | — |
| 2023-11-09 | $0.25 | — | — | — |
| 2023-08-10 | $0.25 | — | — | — |
| 2023-05-11 | $0.25 | — | — | — |
| 2023-02-09 | $0.25 | — | — | — |
| 2022-11-09 | $0.22 | — | — | — |
| 2022-08-11 | $0.22 | — | — | — |
| 2022-05-12 | $0.20 | — | — | — |
| 2022-02-10 | $0.20 | — | — | — |
| 2021-11-10 | $0.18 | — | — | — |
| 2021-08-12 | $0.18 | — | — | — |
Insider Trading (Recent)
Last updated: Aug 12, 2026 1:17pm (1d ago)All SEC Form 4 codes
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-08-04 | Schwab Charles R. | S-Sale | 47,650.00 | $106.08 | $5.1M |
| 2026-08-04 | Schwab-Pomerantz Carolyn | S-Sale | 22,640.00 | $106.36 | $2.4M |
| 2026-08-03 | Schwab Charles R. | S-Sale | 95,250.00 | $105.52 | $10.1M |
| 2026-08-01 | Howard Dennis | F-InKind | 1,292.00 | $104.87 | $135,489 |
| 2026-07-29 | Schwab Charles R. | S-Sale | 95,450.00 | $105.82 | $10.1M |
| 2026-07-28 | Bettinger Walter W | M-OptionExercise | 93,408.00 | $0.00 | $0 |
| 2026-07-28 | Bettinger Walter W | S-Sale | 42,265.00 | $103.86 | $4.4M |
| 2026-07-28 | Bettinger Walter W | S-Sale | 38,263.00 | $105.18 | $4.0M |
| 2026-07-28 | Bettinger Walter W | S-Sale | 12,880.00 | $105.56 | $1.4M |
| 2026-07-28 | Schwab Charles R. | S-Sale | 48,000.00 | $105.60 | $5.1M |
| 2026-07-28 | Schwab Charles R. | G-Gift | 60,000.00 | $0.00 | $0 |
| 2026-07-28 | Howard Dennis | M-OptionExercise | 28,000.00 | $0.00 | $0 |
| 2026-07-28 | Howard Dennis | S-Sale | 28,000.00 | $105.01 | $2.9M |
| 2026-07-28 | Schwab-Pomerantz Carolyn | S-Sale | 22,650.00 | $105.71 | $2.4M |
| 2026-07-28 | Schwab-Pomerantz Carolyn | G-Gift | 271.00 | $0.00 | $0 |
| 2026-07-27 | Bettinger Walter W | M-OptionExercise | 192,488.00 | $0.00 | $0 |
| 2026-07-27 | Bettinger Walter W | S-Sale | 192,488.00 | $103.90 | $20.0M |
| 2026-07-27 | Murtagh Nigel J | M-OptionExercise | 32,947.00 | $0.00 | $0 |
| 2026-07-27 | Murtagh Nigel J | S-Sale | 21,947.00 | $104.00 | $2.3M |
| 2026-07-27 | Murtagh Nigel J | S-Sale | 11,000.00 | $104.03 | $1.1M |
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Narrative Economics
market-narrative step).
AI Lens 4th lens · how AI reaches this business · 5-yr
2026-08-12Schwab's expense line is dominated by human service, onboarding, compliance review and advisor support across a very large headcount; agentic handling of routine service and document/KYC work lets client assets grow faster than employees, and the firm has historically pushed such savings into price/scale rather than losing them.
Cheap intelligence makes cash-yield optimization frictionless: an AI assistant that automatically sweeps idle balances into money funds or T-bills structurally accelerates cash sorting, and Schwab's net interest revenue on low-cost client cash is the single largest profit engine.
Whether AI-driven cash optimization erodes the sweep spread faster than AI cuts cost-to-serve and grows custodied assets. Observable: the trend in bank sweep deposits as a share of total client assets, and non-interest expense per dollar of client assets.
Regulated custody with SIPC/broker-dealer and bank charter status, the RIA custody network with its integrations and transition friction, and multi-decade household trust to hold retirement balances — none of which cheap code produces.
AI Lens thesis
Schwab is hired to safekeep, transact and administer household and advisor assets, and it is paid mainly in spread on client cash plus bps on assets, not in advice hours — so AI's commoditization of financial advice hits a small slice while its commoditization of service labor hits a large cost slice favorably. The real transmission is at the monetized unit: if consumer-facing AI assistants routinely optimize every dollar of idle cash and route orders via API, Schwab keeps the custody rail and the assets but loses the cheap-funding spread and the direct client interface, drifting toward a lower-margin utility. Offsetting that, AI lowers the cost of running an independent advisory practice, expanding the RIA population Schwab custodies for, and regulatory/capital barriers mean AI-native entrants still need a balance sheet and a charter to compete.
What the market may be underestimating
Upside AI slashing the cost of launching and running a small RIA could materially expand the independent-advisor population — Schwab is the default custodian for that expansion and captures assets without adding advisors.
Downside If third-party AI assistants become the household's financial front end, Schwab is demoted to execution/custody plumbing: assets stay, but cross-sell, advice fees and behavioral inertia on cash all weaken at once.
Outcome range spread 43
Claude Reading
The raw quarterly trajectory is genuinely impressive on its face: revenue climbed from $4.69B in Q2'24 to $6.48B in Q1'26 — a 38% jump in seven quarters — with net margins expanding from 28.4% to 38.2% over the same window. Earnings nearly doubled (from $1.33B to $2.48B quarterly). But this is exactly the pattern you'd expect from a rate-sensitive custodian emerging from the 2022-2023 cash-sorting debacle, when clients yanked idle deposits into money market funds and crushed NIM. The right reference frame isn't Q2'24; it's 2021-2022, when Schwab did $18.5-20.8B annual revenue and $5.9-7.2B in net income. 2025's $23.9B/$8.85B looks less like a breakout and more like a cyclical high with modest secular growth on top. The 32.2% earnings CAGR is a base-effect artifact, not a run rate.
The synthesis calls this undervalued with fair value of $162 (+58% upside). I dissent — the fair value math almost certainly extrapolates recent margin and earnings growth that will not compound. Market Forces has the more honest read: this is late-cycle NIM peak, not the start of a new regime. The Fed is cutting, deposit betas work asymmetrically on the way down (loan yields reprice faster than sticky deposit costs — actually a modest positive short-term, but the spread narrative reverses over 12-18 months), and the FCF CAGR of -31.9% against earnings CAGR of +32.2% is the tell. When GAAP earnings roar while cash generation deteriorates, you're looking at either securities portfolio marks reversing, provisioning changes, or working capital contributions that don't repeat. For a bank/broker hybrid, that gap deserves heavy skepticism. Pre-Flight and Thesis Evaluation both flag this correctly; Synthesis appears to ignore it.
The insider ledger reinforces the caution. Every transaction listed from July-August 2026 is a sale or an option-exercise-then-sale — not a single open-market buy. The "Net Insider Buying" secondary signal appears to be miscoded against the raw tape, which shows the opposite. That's a data-integrity flag worth calling out: two prior models are working from contradictory inputs. The ROA of 1.8% is also a reminder that this is a leveraged balance-sheet business ($46B cash, ~$50B equity against a much larger asset base implied by the ROE/ROA spread) — 17.9% ROE on 1.8% ROA means roughly 10x asset leverage, typical for the bank sleeve but sensitive to rate shocks and any AOCI unwind. P/B of 4.2 is not cheap for a business with this ROA profile and this much rate sensitivity.
A careful contrarian to my own view would note: Schwab's advisor custody franchise is genuinely sticky, TD Ameritrade integration synergies are still flowing through, and if the yield curve steepens meaningfully into 2026-2027, NIM could hold above pre-crisis norms for longer than skeptics assume. The narrative layer's "fallen-angel, moderate durability" framing captures this — the moat is real even if the current earnings level isn't the right anchor. But at 23x trailing earnings on what I'd call peak-ish EPS, and 8.6x sales for a business that did 12.7% revenue CAGR (not 22% sustainably), the margin of safety the synthesis claims simply isn't there. Normalizing 2025 earnings to something like $7-7.5B (a blend of 2022 peak and 2024 trough plus modest organic growth) and applying a fair 18-20x multiple gets you $135-150B market cap, or roughly $75-85/share — below current price, not above. The $162 fair value requires believing 38% margins are the new normal; I don't. Fair value is closer to $90-100 than $160.
Where the data is thin: no debt figure disclosed (debt_to_equity=0 is obviously wrong for a bank holding company — bank deposits and FHLB borrowings are the funding stack), no gross/operating margin breakouts, and the "decelerating quarterly trend" flag conflicts with the sequential acceleration in the raw prints ($5.85B → $6.14B → $6.34B → $6.48B is decelerating in growth rate but still positive sequentially). The models disagree with each other on insider activity and on the sustainability question — I side with Market Forces and Thesis Evaluation over Synthesis. Bottom line: quality franchise, cyclically-flattered earnings, priced for continued expansion that won't come. Not a short — the moat is real — but not the 58% upside setup the composite claims.
GPT Reading
What jumps out is not a broken franchise but a very sharp earnings recovery already well in flight. Quarterly revenue has climbed from $4.69B in June 2024 to $6.48B in March 2026, a 38% increase in seven quarters, while net income went from $1.33B to $2.48B, up 86%. The more important detail is the margin trajectory: 28.4% to 38.2%, with every quarter since mid-2024 improving or holding near peak levels. Annual numbers tell the same story: revenue rebounded from $19.61B in 2024 to $23.92B in 2025, and net income surged from $5.94B to $8.85B. That is not a marginal recovery; it is a major normalization of earnings power after the pressure period. For a capital-markets franchise with Schwab’s scale, $46.03B of cash, $49.43B of equity, 17.9% ROE, and $8.76B of free cash flow, a 23.4x P/E is not obviously expensive. It is expensive only if you assume these earnings are near cyclical peak and headed back down.
I do not think the market is wildly wrong to worry about that, but I also do not think the current price reflects a full-blown bubble. At $187.8B market cap, investors are paying about 21x 2025 net income and roughly 7.8x 2025 revenue. That is a premium multiple for a mature financial, yet the underlying business just posted 22% annual revenue growth and roughly 49% recent earnings growth. The key contradiction in the briefing is that some outputs talk as if cash flow is deteriorating or even negative, but the actual figures show $9.31B of operating cash flow and $8.76B of free cash flow in 2025. That does not make Schwab cheap; it does undermine the harsher “value trap” framing. The balance sheet data also matter: debt is shown as zero in the canonical metrics, which may simplify a more complex funding structure, but on the face of the provided numbers this is a cash-rich, strongly profitable company, not a strained spread lender. My read is that the stock deserves a premium to ordinary brokers because the earnings rebound is real and the franchise quality is real, but not the kind of premium that implies 2025-2026 margins should be capitalized as if permanently expanding.
The strongest argument against that view is straightforward: nearly all of the good news is already in the reported numbers, and the stock at $107.89 is not being valued on depressed earnings anymore. Net margin was 37.0% for 2025 versus 30.3% in 2024 and 26.9% in 2023; if that lift was mostly a recovery from abnormal funding pressure, then 2025-2026 may represent a high-water mark rather than a base. Quarterly revenue growth is still positive, but sequential growth has slowed from +9.3% between 3Q24 and 4Q24 to +2.2% between 4Q25 and 1Q26. If rate cuts compress net interest revenue while operating leverage runs out, a 23x earnings multiple can de-rate fast toward the high teens, especially for a company trading at 4.2x book and yielding just 1.1%. A smart bear would also point to the insider tape: while much of it appears to be option-related, the last ten line items are overwhelmingly sales, not open-market conviction buys. If earnings merely flatten around the current $2.4B quarterly run rate instead of growing, upside from here is much less compelling.
I weigh those concerns seriously, but not enough to call the stock overvalued. The reason is that the earnings base now looks more durable than the bear case admits. Schwab has produced four straight quarters above $2.1B of net income and three straight around $2.36B-$2.48B, which suggests stabilization rather than a one-quarter spike. Even if annual earnings settled closer to $9.0B than continued compounding upward, the current valuation is demanding but still serviceable for a dominant platform business with solid FCF conversion and mid-to-high teens ROE. I would not chase it as a deep-value idea, and I do not buy the $160-plus valuation synthesis unless one assumes both sustained margin near 38% and a continued premium multiple. More realistically, fair value feels closer to the low-$100s to low-$120s, with returns from here driven more by execution than rerating. That leaves me mildly positive, not enthusiastic.
What would change my mind is specific evidence that the margin recovery is reversing. If quarterly revenue stalls below roughly $6.0B again and net income drops back under $2.0B for two consecutive quarters, especially with annualized net margin falling toward 32%-34%, I would move bearish because the current multiple would then look too rich for a normalizing spread business. On the other hand, if Schwab can hold quarterly earnings around $2.4B while growing revenue into the high-$6B range and converting that into another year of $9B-plus free cash flow, then the stock likely deserves to trade above $120 and the “cyclical peak” concern would be overstated.
Grok Reading
The numbers tell a recovery-to-plateau story, not a structural breakout and not a collapse. Schwab’s revenue climbed from $4.69B in Q2 2024 to $6.48B in Q1 2026, with net margins expanding from 28.4% to a tight 38–39% band over the last three reported quarters. Full-year 2025 delivered $23.92B in revenue and $8.85B in net income—up 22% and 49% respectively from 2024’s still-depressed $19.61B and $5.94B—while free cash flow of $8.76B converted nearly dollar-for-dollar off that earnings print. That is real cash, not accounting fiction. The 2023–24 trough (cash-sorting after the regional-bank scare, compressed net interest margin) is visible in the annual series: 2023 NI of $5.07B was the low, 2022’s $7.18B the prior peak, and 2025 has now cleared both. Sequential revenue is still rising, but the Secondary signal correctly flags deceleration; year-on-year revenue growth has cooled from the mid-20s toward the mid-teens. At $107.89 and a 23.4x trailing P/E on that $8.85B, with ROE at 17.9% and a P/B of 4.2, the market is paying a quality-franchise multiple for a business that has already re-rated earnings off the trough—not a distressed discount.
Several of the prior-model verdicts are simply wrong on the data. Market Forces calls out “negative free cash flow” when FCF is $8.76B against $548M of capex; that claim is dead on arrival. The same block flags “heavy insider selling” as a cyclical-peak tell, yet the tape is almost entirely option exercise followed by sale—standard liquidity, not a cluster of open-market dumps—and the Secondary layer’s “Net Insider Buying” label is equally unsupported by the ten transactions shown. Valuation Synthesis’s $162–$171 fair value (+58%) requires the market to capitalize mid-teens growth at a mid-to-high-20s multiple indefinitely; that is a best-case re-rating, not a base case, especially with ROA at only 1.8% and a business whose earnings power is still mechanically tied to the deposit beta and the short end of the curve. Thesis Evaluation’s −22 score over-weights the “cyclical peak” bear while under-weighting that three consecutive quarters have now held ~38% margins without rolling over. The cleanest read is a mature earner that has normalized off an anomalous trough, throws off high-teens ROE and excellent cash conversion, and is priced as exactly that—not as a compounder deserving 30x, and not as a value trap.
The strongest case against this view is the FCF CAGR of −31.9% sitting beside a 32% earnings CAGR: that divergence implies earlier years carried outsized working-capital or deposit-flow tailwinds that are not recurring, so trailing FCF quality may overstate steady-state owner earnings. A second opponent point is the 23x multiple itself on what is still a rate-sensitive NII engine; if the Fed cuts through 2026 and deposit costs re-price slower than asset yields, the 38% margin band compresses and the stock is earning a growth multiple on flat-to-down earnings. Third, revenue confidence is only “adequate” with a decelerating quarterly trend—Q1 2026’s $6.48B is only 2% above Q4 2025—so the easy NIM recovery bounce may already be in the run-rate. I weigh these differently because current FCF still matches NI, the balance sheet carries $46B in cash against $49B of equity with a reported debt-to-equity of zero (deposit liabilities are the real leverage, and they stabilized), and the custody/RIA platform moat is not impaired by the rate cycle. The discount to the bull DCF is partly earned skepticism about NIM durability; it is not evidence the franchise is decaying.
I would flip to a clear undervalued, high-conviction long if two consecutive quarters show revenue re-accelerating above 15% YoY while margins hold ≥37%, or if the multiple compresses toward 18x on trailing earnings without a fundamental break—roughly $90–95 on current NI. I would flip outright bearish if Q2–Q3 2026 NI falls below $2.1B as rates cut, or if client asset outflows reappear at 2023 scale.
Big-3 Panel — where each AI stands
Claude — Second Response · fairly valued changed direction
VERDICT: Holding fair-to-modestly-overvalued at $108; revised fair value $95-110 (up from $90-100) after conceding FCF quality and margin persistence, but rejecting the $115-135 zone as still pricing in NIM durability the rate cycle won't grant
GPT and Grok both landed close to each other ($115-135) and both explicitly rejected the $162 synthesis, so the "drift toward majority" trap here would be sliding to $110-120. I need to check whether their specific arguments dismantle my $90-100 call, or whether we're just disagreeing on how much of 2025 margin is durable.
The argument that moved me partway: Grok is right that I was sloppy on the FCF point. $8.76B FCF against $8.85B NI in 2025 is ~99% conversion — that's not a red flag, it's clean. The "FCF CAGR -31.9%" is a base-year artifact from an anomalously high prior print, not evidence of deteriorating cash quality in the current period. I leaned on Market Forces' framing there and should have checked the actual 2025 number. Similarly, GPT's point that four straight quarters above $2.1B and three around $2.36-2.48B looks more like stabilization than a one-quarter spike is fair — my "peak" framing implicitly assumed a rollover that hasn't shown up in the tape yet. That pushes my normalized earnings estimate up from $7-7.5B toward $8.0-8.5B.
What didn't move me: neither colleague engaged the core rate-cycle asymmetry. Deposit betas on the way down are sticky short-term but the NIM tailwind from asset repricing is finite, and both of them concede the multiple de-rates fast if margins compress toward 33-34%. Grok's own bear-flip trigger (NI below $2.1B in Q2-Q3 2026) is exactly what a Fed cutting cycle plausibly delivers. At 23x trailing on earnings that are 45%+ above the 2023 trough, with ROA still only 1.8% and P/B of 4.2, I don't see the margin of safety either colleague claims exists in the $115-135 range. Splitting the difference: normalized $8B earnings × 18-19x = $145-150B market cap = $83-86/share. I'll widen my range slightly to $95-110 to reflect the durability evidence I underweighted, which puts current price at the top of fair, not below it.
GPT — Second Response · fairly valued revised
VERDICT: Roughly fairly valued at $107.89, with fair value centered around $100-$115; attractive below ~$100, stretched above ~$120 absent proof margins can hold through rate cuts.
Claude’s push on cyclicality moved me some, mainly on one point I underweighted: the provided “debt = 0” style balance-sheet simplification is not economically meaningful for Schwab, and the ROE/ROA spread does remind you this is a leveraged spread business, not a software platform. That matters because 23x trailing earnings on a rate-sensitive broker-bank hybrid is less forgiving than my first pass implied. But his harsher conclusion still leans too heavily on a cash-flow warning I do not think survives the actual reported year. A negative multi-year FCF CAGR versus positive earnings CAGR can absolutely flag normalization or nonrepeatable flows, but 2025 itself still shows $9.31B operating cash flow and $8.76B FCF against $8.85B net income. That is not the profile of earnings detached from cash in the current period. I also don’t think the insider tape adds much beyond “no bullish signal”: option-exercise sales are not open-market conviction buys, but they are weaker evidence of overvaluation than Claude suggests.
Grok’s framing is closer to where I land after re-reading the set: this is a recovery-to-plateau, not a structural breakout and not a value trap. The key fact pattern remains four straight quarters above $2.1B net income, three clustered around $2.36B-$2.48B, and sequential revenue still rising even as growth decelerates. That does support durability, but not a premium multiple expansion story. Where I revise is in tightening my valuation range lower than my original $115-$120 bias, because the colleague critique correctly highlights that 2025 likely contains above-normal NIM support and the market is no longer paying a trough multiple. I still reject the $75-$85 bear normalization as too punitive for a franchise with this custody moat, ROE, and current cash conversion, but I no longer see “modestly undervalued” as the clean base case. Best read: roughly fair, with value emerging closer to the low $100s or below and upside capped unless margins prove sticky through cuts.
Grok — Second Response · undervalued revised
VERDICT: Modestly undervalued quality compounder at $108—fair value nearer $115–125; 23x is full if NIM rolls, still serviceable if $9B earnings base holds
Claude’s reference-frame argument lands: anchoring to the 2021-22 $18-21B / $6-7B era rather than the 2023-24 trough correctly reframes 2025’s $23.9B / $8.85B as a cyclical high with modest secular lift, not a structural breakout. That, plus the explicit FCF-CAGR divergence I already flagged, undercuts my prior willingness to capitalize mid-teens growth at anything above low-20s multiples. The sequential deceleration to +2% and the option-driven insider sales tape further erode the case for $125-135 as base-case fair value. GPT’s milder read—that four quarters of $2.3-2.5B NI look like a stabilized run-rate rather than a one-off spike—is the better counterweight; Claude’s $7-7.5B normalized earnings haircut is simply too severe given dollar-for-dollar FCF conversion and the still-intact custody moat.
I therefore revise the fair-value band downward while rejecting the outright overvalued call. At 23x trailing on what is now peak-ish but not obviously collapsing earnings power, $108 embeds little margin of safety if deposit betas reverse, yet the balance-sheet cash, 18% ROE, and platform stickiness still support a modest premium to ordinary brokers. The stock is no longer a clear discount; it is a quality franchise priced for roughly flat-to-low-single-digit earnings growth from here.
Advanced Analysis Forensic deep-dive · four lenses
Schwab put up its strongest year of the window in 2025: revenue $23.92B (up from $19.61B), net income $8.85B (up 49% YoY), and FCF $8.76B with OCF/NI at 1.2x and accruals at -0.2% of assets - earnings are backed by cash. The 2023 dip (rev $18.84B, NI $5.07B) reflected the deposit-flight / rate-shock episode; the trajectory since is clear recovery to new highs. Liquid cash of $46.03B against no net debt on this framing gives ample operating cushion for a franchise of this scale. Capital return is disciplined: diluted shares fell from 2.07B (2021) to 1.90B (2025), a -2.1% CAGR, with buyback/SBC at 852% - SBC (1.3% of revenue) is being more than absorbed. That is genuine per-share value concentration, not the dilution treadmill common in financials. The soft spots are structural rather than forensic. Altman Z at 0.43 flags 'distress' but the model is essentially meaningless for a broker-dealer/bank whose balance sheet is client assets and interest-earning securities - noise, not signal. Insider activity is heavily sell-skewed (32 sells vs 1 buy, $68M vs $1.8M) despite the 'net buyer' label in the context; the tape is routine option-exercise-and-sell by execs, not a red flag but also not a conviction signal. Gross/operating margin fields read 0 because of financials-industry presentation, so unit economics have to be inferred from the NI/revenue ratio (~37% in 2025), which is robust.
Verify before trusting this (6)
- AOCI and HTM securities marks / unrealized loss position on the investment portfolio
- Deposit trends and cash sorting behavior post-2023 outflow episode
- Segment mix between net interest revenue and asset-management/trading fees
- Capital ratios (Tier 1, SLR) and any regulatory constraints on buybacks
- Ameritrade integration completion status and any residual charges
- Concentration of client assets and pricing power on advisory fees
The e2e composite pins fair value at $162 and signal-adjusted at $171, implying 50-58% upside. I want to trust that but not fully - the anchored PE of $185 leans on peak-cycle NIM expectations and the DCF at $151 already bakes in normalization. Haircutting the composite toward the DCF and adding a modest quality premium for a Strong (not Fortress) broker-bank, my honest deserved value sits closer to $135-150, or roughly 25-38% above the $108.56 price. That is a real gap, not a mirage, but it is not a fat-pitch dislocation either. What is priced in at $108 looks like the bear case partially winning: fee compression continues, NIM re-expansion disappoints, and the 2023 deposit-flight scare recurs. The bull case - defensive compounder, scale moat, buybacks shrinking the float, NIM tailwind - is only partially credited. Earnings quality is clean and the share count is actually falling, which supports the higher end of my deserved range. Net: modestly cheap on skeptical numbers, genuinely cheap if you believe the composite. Call it Modestly Cheap with room to add on weakness.
Verify before trusting this (5)
- Bank deposit trends and cash sorting behavior in latest 10-Q
- NIM guidance and rate sensitivity disclosures
- Buyback pace and remaining authorization
- Any one-off gains in the record earnings print
- Client asset flows and fee-rate trajectory
The macro tape is mildly supportive: risk-on regime (+47), VIX 15.3, S&P near highs. Schwab's low beta (0.75) means the tape neither helps nor hurts much, but the direction is friendly. More importantly, the price is running - 22% recent versus 12.7% long-term CAGR, with +10pp over three years - which tells you the market is already quietly re-rating this name off its fallen-angel lows. Momentum itself becomes a self-reinforcing tailwind as trend-followers and index flows pile in. The narrative is a moderate-intensity, moderate-durability fallen-angel story with low cult factor - not a mania, not a collapse, just a slow rehabilitation. That's exactly the kind of story that benefits from a calm tape because there's no acute fear catalyst to reignite the bear case (fintech disruption, fee compression) and rate normalization headlines (10y at 4.72%) actually reinforce the bull NIM thesis. News flow is benign-to-constructive: product launches (single stock futures, agentic account-opening AI integration), rising STAX trading activity, retail engagement data. The Linqto litigation is a minor overhang but not narrative-moving. Net: modest but real tailwind pressure - not euphoric, but the wind is at its back.
Verify before trusting this (4)
- Whether Q3 net interest revenue guidance reinforces or breaks the NIM-normalization narrative
- Any escalation in the Linqto/Forge litigation with a quantifiable damages figure
- Sector rotation signals: if capital markets underperform financials broadly, the fallen-angel rehabilitation stalls
- VIX spike above 20 or S&P breaking below its 50d - would test how much of the recent run is tape-dependent
Schwab is hired to safekeep, transact and administer household and advisor assets, and it is paid mainly in spread on client cash plus bps on assets, not in advice hours — so AI's commoditization of financial advice hits a small slice while its commoditization of service labor hits a large cost slice favorably. The real transmission is at the monetized unit: if consumer-facing AI assistants routinely optimize every dollar of idle cash and route orders via API, Schwab keeps the custody rail and the assets but loses the cheap-funding spread and the direct client interface, drifting toward a lower-margin utility. Offsetting that, AI lowers the cost of running an independent advisory practice, expanding the RIA population Schwab custodies for, and regulatory/capital barriers mean AI-native entrants still need a balance sheet and a charter to compete.
None surfaced.
Verify before trusting this (8)
- Sweep deposit balance trajectory
- Net interest margin decomposition
- Client cash yield-seeking behavior
- Third-party API/agent access policy
- Aggregator-driven order flow share
- Direct app engagement metrics
- Branch and service headcount
- Digital advice asset growth